Clinical Trial Update: Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the relevance of monitoring blood and salivary levels of drugs used in rheumatic autoimmune diseases, including SLE, with completed r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus
• Juvenile Systemic Lupus Erythematosus
• Systemic Lupus Erythematosus

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Systemic Lupus Erythematosus (SLE), Juvenile SLE | Phase 4 | Status: COMPLETED | Results posted: 2021-12-16